Misty Oldham to Clinical Trials as Topic
This is a "connection" page, showing publications Misty Oldham has written about Clinical Trials as Topic.
Connection Strength
0.050
-
Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection. Ann Pharmacother. 2014 Mar; 48(3):395-403.
Score: 0.050
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.